학술논문
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses.
Document Type
Article
Author
Al‐Riyami, Arwa Z.; Burnouf, Thierry; Yazer, Mark; Triulzi, Darrell; Kumaş, Levent Tufan; Sağdur, Levent; Pelit, Nil Banu; Bazin, Renée; Hindawi, Salwa I.; Badawi, Maha A.; Patidar, Gopal K.; Pandey, Hem Chandra; Chaurasia, Rahul; Fachini, Roberta Maria; Scuracchio, Patrícia; Wendel, Silvano; Ang, Ai Leen; Ong, Kiat Hoe; Young, Pampee; Ihalainen, Jarkko
Source
Subject
*NEUTRALIZATION tests
*CONVALESCENT plasma
*COVID-19
*COUGH
*HEALTH services administration
*MEDICAL research
*MEDICAL personnel
*
*
*
*
*
*
Language
ISSN
0042-9007
Abstract
Donor recruitment CCP donor recruitment challenges were mainly attributable to the BC lack of access to qualified CCP donor lists. Therefore, most patients would likely not qualify as CCP donor if they have received CCP since they would need to be deferred for 12 months after their CCP transfusion, by which time their neutralizing antibody titres will likely fall too low for them to be CCP donors. We found out that the highest success rate to recruit CCP donors was by requesting physicians, hospitals, laboratories, and public health departments to inform recently recovered COVID-19 patients to become CCP donors. Question 4 In addition to meeting all donor eligibility criteria that are applied to regular plasma donors, CCP donors must have evidence of a RT-PCR positive SARS-CoV-2 test or be presumptive positive. Question 4 All CCP donors (who donate for the clinical trial or the fractionation program) must have a confirm test result of past COVID-19 infection prior to being accepted as CCP donors. [Extracted from the article]